Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2024 is 21.91% vs 64.04% in Mar 2023
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2024 is 19.62% vs 20.38% in Mar 2023
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2024 is 18.96% vs 41.64% in Mar 2023
Compare Balance Sheet Results of Fredun Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.70
25.06
-20.36
-81.25%
Share Warrants & Outstandings
Total Reserve
115.20
300.97
-185.77
-61.72%
Shareholder's Funds
121.47
326.02
-204.55
-62.74%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
12.80
0.00
12.80
0.00%
Secured Loans
12.80
0.00
12.80
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
4.14
-2.08
6.22
299.04%
Other Long Term Liabilities
0.00
0.06
-0.06
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.37
2.03
0.34
16.75%
Total Non-Current Liabilities
19.30
0.01
19.29
192,900.00%
Current Liabilities
Trade Payables
62.95
156.84
-93.89
-59.86%
Other Current Liabilities
11.17
11.00
0.17
1.55%
Short Term Borrowings
92.71
10.50
82.21
782.95%
Short Term Provisions
0.00
0.17
-0.17
-100.00%
Total Current Liabilities
166.83
178.51
-11.68
-6.54%
Total Liabilities
307.60
504.55
-196.95
-39.03%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
62.98
111.06
-48.08
-43.29%
Less: Accumulated Depreciation
16.40
61.36
-44.96
-73.27%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
46.57
49.70
-3.13
-6.30%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.27
-0.27
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
51.95
-51.95
-100.00%
Long Term Loans & Advances
3.36
2.64
0.72
27.27%
Other Non Current Assets
0.46
15.30
-14.84
-96.99%
Total Non-Current Assets
50.40
128.38
-77.98
-60.74%
Current Assets Loans & Advances
Current Investments
0.81
53.86
-53.05
-98.50%
Inventories
175.00
74.48
100.52
134.96%
Sundry Debtors
64.85
215.87
-151.02
-69.96%
Cash and Bank
1.35
19.74
-18.39
-93.16%
Other Current Assets
1.44
11.48
-10.04
-87.46%
Short Term Loans and Advances
13.76
0.75
13.01
1,734.67%
Total Current Assets
257.20
376.17
-118.97
-31.63%
Net Current Assets (Including Current Investments)
90.37
197.66
-107.29
-54.28%
Total Current Assets Excluding Current Investments
256.39
322.31
-65.92
-20.45%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
307.60
504.55
-196.95
-39.03%
Contingent Liabilities
0.00
25.26
-25.26
-100.00%
Total Debt
105.51
10.50
95.01
904.86%
Book Value per share (adjusted)
255.15
32.53
222.62
684.35%
Annual - Borrowings
Borrowings 105.51 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 21.91% vs 64.04% in Mar 2023
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 46.57 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 19.62% vs 20.38% in Mar 2023
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 257.20 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 18.96% vs 41.64% in Mar 2023






